Methods for tracking B-cell repertoires and clonal history in normal and malignant B-cells based on immunoglobulin variable region (IGV) gene analysis have developed rapidly with the advent of massive parallel next-generation sequencing (mpNGS) protocols. mpNGS permits a depth of analysis of IGV genes not hitherto feasible, and presents challenges of bioinformatics analysis, which can be readily met by current pipelines. This strategy offers a potential resolution of B-cell usage at a depth that may capture fully the natural state, in a given biological setting. Conventional methods based on RT-PCR amplification and Sanger sequencing are also available where mpNGS is not accessible. Each method offers distinct advantages. Conventional metho...
Several methods have been developed for the detection of minimal residual disease (MRD) in B cell tu...
The B cell receptor (BCR) repertoire is highly diverse. Repertoire diversity is achieved centrally b...
B cell lymphoma (BCL) comprises a biologically and clinically heterogeneous group of tumors deriving...
International audienceOne of the hallmarks of B lymphoid malignancies is a B cell clone characterize...
In human immune system, V(D)J recombination produces an enormously large repertoire of immunoglobuli...
Ig gene (IG) clonality analysis has an important role in the distinction of benign and malignant B-c...
Eileen M Boyle,1,2 Brian A Walker,1 Christopher P Wardell,1 Xavier Leleu,2 Faith E Davies,1 Gareth J...
: Evaluation of B-cell clonality can be challenging in the interpretation of lymphoid infiltrates on...
B cells fulfill an important role in the adaptive immunity. Upon activation and immunoglobulin (IG) ...
International audienceWithin the EuroClonality-NGS group, immune repertoire analysis for target iden...
A considerable number of studies on hematological malignancies have recently demonstrated that the i...
Assessment of the presence of clonal lymphoproliferations via polymerase chain reaction (PCR)-based ...
Amplicon-based next-generation sequencing (NGS) of immunoglobulin (IG) and T-cell receptor (TR) gene...
During B cell maturation, the complex process of immunoglobulin (IG) gene V(D)J recombination couple...
The B cell receptor (BCR) repertoire is highly diverse. Repertoire diversity is achieved centrally b...
Several methods have been developed for the detection of minimal residual disease (MRD) in B cell tu...
The B cell receptor (BCR) repertoire is highly diverse. Repertoire diversity is achieved centrally b...
B cell lymphoma (BCL) comprises a biologically and clinically heterogeneous group of tumors deriving...
International audienceOne of the hallmarks of B lymphoid malignancies is a B cell clone characterize...
In human immune system, V(D)J recombination produces an enormously large repertoire of immunoglobuli...
Ig gene (IG) clonality analysis has an important role in the distinction of benign and malignant B-c...
Eileen M Boyle,1,2 Brian A Walker,1 Christopher P Wardell,1 Xavier Leleu,2 Faith E Davies,1 Gareth J...
: Evaluation of B-cell clonality can be challenging in the interpretation of lymphoid infiltrates on...
B cells fulfill an important role in the adaptive immunity. Upon activation and immunoglobulin (IG) ...
International audienceWithin the EuroClonality-NGS group, immune repertoire analysis for target iden...
A considerable number of studies on hematological malignancies have recently demonstrated that the i...
Assessment of the presence of clonal lymphoproliferations via polymerase chain reaction (PCR)-based ...
Amplicon-based next-generation sequencing (NGS) of immunoglobulin (IG) and T-cell receptor (TR) gene...
During B cell maturation, the complex process of immunoglobulin (IG) gene V(D)J recombination couple...
The B cell receptor (BCR) repertoire is highly diverse. Repertoire diversity is achieved centrally b...
Several methods have been developed for the detection of minimal residual disease (MRD) in B cell tu...
The B cell receptor (BCR) repertoire is highly diverse. Repertoire diversity is achieved centrally b...
B cell lymphoma (BCL) comprises a biologically and clinically heterogeneous group of tumors deriving...